Panagora Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,414
| Closed | -$222K | – | 1507 |
|
|
2022
Q1 | $222K | Buy |
+5,414
| New | +$239K | ﹤0.01% | 1431 |
|
|
2021
Q3 | – | Sell |
-31
| Closed | -$2K | – | 1909 |
|
|
2021
Q2 | $2K | Sell |
31
-878
| -97% | -$56.4K | ﹤0.01% | 2626 |
|
|
2021
Q1 | $84K | Sell |
909
-4,516
| -83% | -$463K | ﹤0.01% | 2073 |
|
|
2020
Q4 | $486K | Sell |
5,425
-23,149
| -81% | -$2.12M | ﹤0.01% | 1239 |
|
|
2020
Q3 | $2.95M | Buy |
28,574
+26,788
| +1,500% | +$2.89M | 0.02% | 521 |
|
|
2020
Q2 | $141K | Buy |
1,786
+1,154
| +183% | +$86K | ﹤0.01% | 1672 |
|
|
2020
Q1 | $36K | Sell |
632
-2,145
| -77% | -$124K | ﹤0.01% | 1958 |
|
|
2019
Q4 | $150K | Sell |
2,777
-820
| -23% | -$44.5K | ﹤0.01% | 1699 |
|
|
2019
Q3 | $188K | Sell |
3,597
-3,534
| -50% | -$165K | ﹤0.01% | 1646 |
|
|
2019
Q2 | $344K | Sell |
7,131
-228,569
| -97% | -$11M | ﹤0.01% | 1572 |
|
|
2019
Q1 | $11.9M | Buy |
235,700
+38,143
| +19% | +$2.25M | 0.05% | 324 |
|
|
2018
Q4 | $11.7M | Buy |
197,557
+3,135
| +2% | +$202K | 0.05% | 285 |
|
|
2018
Q3 | $12.8M | Buy |
194,422
+43,234
| +29% | +$2.52M | 0.05% | 313 |
|
|
2018
Q2 | $7.63M | Buy |
151,188
+7,950
| +6% | +$414K | 0.03% | 409 |
|
|
2018
Q1 | $7.54M | Buy |
143,238
+10,290
| +8% | +$513K | 0.03% | 424 |
|
|
2017
Q4 | $6.18M | Buy |
132,948
+122,079
| +1,123% | +$5.14M | 0.02% | 492 |
|
|
2017
Q3 | $440K | Sell |
10,869
-14,948
| -58% | -$541K | ﹤0.01% | 1399 |
|
|
2017
Q2 | $875K | Sell |
25,817
-151,259
| -85% | -$4.67M | ﹤0.01% | 1168 |
|
|
2017
Q1 | $5.14M | Buy |
177,076
+6,891
| +4% | +$210K | 0.02% | 582 |
|
|
2016
Q4 | $5.59M | Sell |
170,185
-63,695
| -27% | -$1.91M | 0.03% | 529 |
|
|
2016
Q3 | $7.37M | Buy |
233,880
+96,811
| +71% | +$2.81M | 0.04% | 442 |
|
|
2016
Q2 | $3.85M | Buy |
137,069
+6,037
| +5% | +$237K | 0.02% | 640 |
|
|
2016
Q1 | $4.76M | Hold |
131,032
| – | – | 0.02% | 592 |
|
|
2015
Q4 | $5.24M | Buy |
131,032
+75,829
| +137% | +$2.64M | 0.03% | 535 |
|
|
2015
Q3 | $1.57M | Buy |
55,203
+11,459
| +26% | +$378K | 0.01% | 845 |
|
|
2015
Q2 | $1.44M | Buy |
43,744
+42,427
| +3,221% | +$1.32M | 0.01% | 937 |
|
|
2015
Q1 | $38K | Sell |
1,317
-8,137
| -86% | -$233K | ﹤0.01% | 2127 |
|
|
2014
Q4 | $257K | Buy |
9,454
+4,874
| +106% | +$116K | ﹤0.01% | 1536 |
|
|
2014
Q3 | $98K | Sell |
4,580
-232,666
| -98% | -$5.33M | ﹤0.01% | 1872 |
|
|
2014
Q2 | $5.33M | Sell |
237,246
-58,588
| -20% | -$1.36M | 0.03% | 498 |
|
|
2014
Q1 | $7.48M | Buy |
295,834
+72,064
| +32% | +$1.82M | 0.04% | 435 |
|
|
2013
Q4 | $5.14M | Buy |
+223,770
| New | +$4.67M | 0.02% | 537 |
|
Other funds holding EBS
Panagora Asset Management's EBS Position: Q2 2022 in Review
Panagora Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 5,414 shares — an estimated $222K sold.
Panagora Asset Management first reported a position in EBS in Q4 2013 and held it in 32 quarters. The position peaked at $12.8M in Q3 2018. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.
- Panagora Asset Management reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
- Panagora Asset Management sold 5,414 Emergent Biosolutions shares in Q2 2022, an estimated $222K.
- Panagora Asset Management first reported a position in Emergent Biosolutions in Q4 2013 and held it in 32 quarters.
- Panagora Asset Management's Emergent Biosolutions position peaked at $12.8M in Q3 2018.
- 232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.
Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.